• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAUSCH + LOMB BAUSCH + LOMB INJECTOR SYSTEM CARTRIDGE; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAUSCH + LOMB BAUSCH + LOMB INJECTOR SYSTEM CARTRIDGE; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL) Back to Search Results
Model Number BLIS-X1
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Vitrectomy (2643); No Code Available (3191); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 11/17/2020
Event Type  Injury  
Manufacturer Narrative
The investigation is on-going.A follow up report will be sent when additional information becomes available.
 
Event Description
It was reported that the 1-piece intraocular lens (iol) was unstable in the bag and wasn¿t able to be positioned properly in the capsular bag.The lens was fully injected prior to removal.The iol was removed intraoperatively and replaced with a different model and diopter iol.The incision was enlarged to remove the lens and sutures were required.A vitrectomy was performed.No other patient injury was reported.Additional information has been requested.
 
Manufacturer Narrative
The device was not returned for evaluation.An analysis of production records could not be performed, as no lot number was provided.Based upon the complaint trend review, the volume of complaints is within the acceptable control limits and no complaint trend is observed.The trend analysis, risk analysis and directions for use review are considered acceptable, with the product performing within anticipated rates.Based on the information available a definitive root cause could not be determined.However, the most likely root cause is associated with operational context.The proper loading of the intraocular lens (iol) in accordance with the directions for use (dfu), including the use of adequate amounts of viscoelastic in the cartridge is essential for the performance of the injector and its cartridge.No additional investigation or corrective action is necessary at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BAUSCH + LOMB INJECTOR SYSTEM CARTRIDGE
Type of Device
FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)
Manufacturer (Section D)
BAUSCH + LOMB
rochester NY 14609
MDR Report Key11167000
MDR Text Key228699071
Report Number0001313525-2021-00010
Device Sequence Number1
Product Code MSS
Combination Product (y/n)Y
PMA/PMN Number
K131958
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor
Type of Report Initial,Followup
Report Date 12/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberBLIS-X1
Device Lot Number222
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received01/13/2021
Supplement Dates Manufacturer Received02/17/2021
Supplement Dates FDA Received03/15/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
AMVISC, VISCOAT, ENVISTA INTRAOCULAR LENS
Patient Outcome(s) Required Intervention;
Patient Age73 YR
-
-